Citations (126)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Marissa Mock, Alex W. Jacobitz, Christopher James Langmead, Athena Sudom, Daniel Yoo, Sara C. Humphreys, Mai Alday, Larysa Alekseychyk, Nicolas Angell, Vivian Bi, Hannah Catterall, Chen-Chun Chen, Hui-Ting Chou, Kip P. Conner, Kevin D. Cook, Ana R. Correia, Andrew Dykstra, Sudipa Ghimire-Rijal, Kevin Graham, Peter Grandsard, Joon Huh, John O. Hui, Mani Jain, Victoria Jann, Lei Jia, Sheree Johnstone, Neelam Khanal, Carl Kolvenbach, Linda Narhi, Rupa Padaki, Emma M. Pelegri-O’Day, Wei Qi, Vladimir Razinkov, Austin J. Rice, Richard Smith, Christopher Spahr, Jennitte Stevens, Yax Sun, Veena A. Thomas, Sarah van Driesche, Robert Vernon, Victoria Wagner, Kenneth W. Walker, Yangjie Wei, Dwight Winters, Melissa Yang & Iain D. G. Campuzano. (2023) Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies. mAbs 15:1.
Read now
Read now
Carl Mieczkowski, Xuejin Zhang, Dana Lee, Khanh Nguyen, Wei Lv, Yanling Wang, Yue Zhang, Jackie Way & Jean-Michel Gries. (2023) Blueprint for antibody biologics developability. mAbs 15:1.
Read now
Read now
Monica L. Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif T. Gjølberg, Timothy P. Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus R. Liedl, Peter M. Tessier, John McCafferty & Andreas H. Laustsen. (2023) Assessing developability early in the discovery process for novel biologics. mAbs 15:1.
Read now
Read now
Jonathan Schmitt, Abbas Razvi & Christoph Grapentin. (2023) Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networks. mAbs 15:1.
Read now
Read now
Christopher Negron, Joyce Fang, Michael J. McPherson, W. Blaine Stine$suffix/text()$suffix/text() & Andrew J. McCluskey. (2022) Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment. mAbs 14:1.
Read now
Read now
Marco A. Blanco. (2022) Computational models for studying physical instabilities in high concentration biotherapeutic formulations. mAbs 14:1.
Read now
Read now
Pin-Kuang Lai, Austin Gallegos, Neil Mody, Hasige A. Sathish & Bernhardt L. Trout. (2022) Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeutics. mAbs 14:1.
Read now
Read now
Rahmad Akbar, Habib Bashour, Puneet Rawat, Philippe A. Robert, Eva Smorodina, Tudor-Stefan Cotet, Karine Flem-Karlsen, Robert Frank, Brij Bhushan Mehta, Mai Ha Vu, Talip Zengin, Jose Gutierrez-Marcos, Fridtjof Lund-Johansen, Jan Terje Andersen & Victor Greiff. (2022) Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies. mAbs 14:1.
Read now
Read now
Pin-Kuang Lai, Gaurav Ghag, Yao Yu, Veronica Juan, Laurence Fayadat-Dilman & Bernhardt L. Trout. (2021) Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions. mAbs 13:1.
Read now
Read now
Emily K. Makowski, Lina Wu, Priyanka Gupta & Peter M. Tessier. (2021) Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods. mAbs 13:1.
Read now
Read now
Theresa K. Cloutier, Chaitanya Sudrik, Neil Mody, Sathish A. Hasige & Bernhardt L. Trout. (2020) Molecular computations of preferential interactions of proline, arginine.HCl, and NaCl with IgG1 antibodies and their impact on aggregation and viscosity. mAbs 12:1.
Read now
Read now
Joschka Bauer, Sven Mathias, Sebastian Kube, Kerstin Otte, Patrick Garidel, Martin Gamer, Michaela Blech, Simon Fischer & Anne R Karow-Zwick. (2020) Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain. mAbs 12:1.
Read now
Read now
Marc Bailly, Carl Mieczkowski, Veronica Juan, Essam Metwally, Daniela Tomazela, Jeanne Baker, Makiko Uchida, Ester Kofman, Fahimeh Raoufi, Soha Motlagh, Yao Yu, Jihea Park, Smita Raghava, John Welsh, Michael Rauscher, Gopalan Raghunathan, Mark Hsieh, Yi-Ling Chen, Hang Thu Nguyen, Nhung Nguyen, Dan Cipriano & Laurence Fayadat-Dilman. (2020) Predicting Antibody Developability Profiles Through Early Stage Discovery Screening. mAbs 12:1.
Read now
Read now
Cholpon Tilegenova, Saeed Izadi, Jianping Yin, Christine S. Huang, Jiansheng Wu, Diego Ellerman, Sarah G. Hymowitz, Benjamin Walters, Cleo Salisbury & Paul J. Carter. (2020) Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies. mAbs 12:1.
Read now
Read now
Joseph D. Schrag, Marie-Ève Picard, Francis Gaudreault, Louis-Patrick Gagnon, Jason Baardsnes, Mahder S. Manenda, Joey Sheff, Christophe Deprez, Cassio Baptista, Hervé Hogues, John F. Kelly, Enrico O. Purisima, Rong Shi & Traian Sulea. (2019) Binding symmetry and surface flexibility mediate antibody self-association. mAbs 11:7, pages 1300-1318.
Read now
Read now
Chaitanya Sudrik, Theresa Cloutier, Phuong Pham, Hardeep S. Samra & Bernhardt L. Trout. (2017) Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies. mAbs 9:7, pages 1155-1168.
Read now
Read now
Dheeraj S. Tomar, Li Li, Matthew P. Broulidakis, Nicholas G. Luksha, Christopher T. Burns, Satish K. Singh & Sandeep Kumar. (2017) In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions. mAbs 9:3, pages 476-489.
Read now
Read now
Yanan Cui, Ping Cui, Binlong Chen, Suxin Li & Hua Guan. (2017) Monoclonal antibodies: formulations of marketed products and recent advances in novel delivery system. Drug Development and Industrial Pharmacy 43:4, pages 519-530.
Read now
Read now
James C. Geoghegan, Ryan Fleming, Melissa Damschroder, Steven M. Bishop, Hasige A. Sathish & Reza Esfandiary. (2016) Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering. mAbs 8:5, pages 941-950.
Read now
Read now
Articles from other publishers (107)
Sumel Ashique, Prathap Madeswara Guptha, Jovita Kanoujia, Ashish Garg, Afzal Hussain, S. Mohana Lakshmi & Neeraj Mishra. 2024. Molecular Pharmaceutics and Nano Drug Delivery. Molecular Pharmaceutics and Nano Drug Delivery
79
102
.
Nanyang Zhao, Junfeng Liu, Mingcheng Bi, Zhongbin Xu, Jing Zhou, Jisong Ding & Qiong Wu. (2023) In situ flow state characterization of molten resin at the inner mold in injection molding. Journal of Applied Polymer Science.
Crossref
Crossref
Yangjie Wei, Wei Qi, Erick Maglalang, Emma M. Pelegri-O’Day, Michelle Luong, Vladimir Razinkov & Christopher Sloey. (2023) Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions. Molecular Pharmaceutics 20:12, pages 6420-6428.
Crossref
Crossref
Kamal Bhandari, Yangjie Wei, Brendan R. Amer, Emma M. Pelegri-O’Day, Joon Huh & Jeremy D. Schmit. (2023) Prediction of Antibody Viscosity from Dilute Solution Measurements. Antibodies 12:4, pages 78.
Crossref
Crossref
Subin Yang, Mijung Jin, Chi Soo Park, Chulmin Moon, Mirae Kim, Jieun Kim, Leeseul Jang, Ji Yeon Jang, Chang Myeong Jeong & Ha Hyung Kim. (2023) Identification, quantification, and structural role of N-glycans in two highly purified isoforms of sheep testicular hyaluronidase. International Journal of Biological Macromolecules 252, pages 126437.
Crossref
Crossref
Noemi P. Meza, Colin A. Hardy, Kylie H. Morin, Chengbin Huang, Smita Raghava, Jing Song, Jingtao Zhang & Ying Wang. (2023) Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay. Molecular Pharmaceutics 20:11, pages 5842-5855.
Crossref
Crossref
Amjad A. Chowdhury, Neha Manohar, Alfredo Lanzaro, William D. Kimball, Marta A. Witek, Mahlet A. Woldeyes, Ranajoy Majumdar, Ken K. Qian, Shifeng Xu, Richard E. Gillilan, Qingqiu Huang, Thomas M. Truskett & Keith P. Johnston. (2023) Characterizing Protein–Protein Interactions and Viscosity of a Monoclonal Antibody from Low to High Concentration Using Small-Angle X-ray Scattering and Molecular Dynamics Simulations. Molecular Pharmaceutics 20:11, pages 5563-5578.
Crossref
Crossref
Iain D. G. Campuzano. (2023) A Research Journey: Over a Decade of Denaturing and Native-MS Analyses of Hydrophobic and Membrane Proteins in Amgen Therapeutic Discovery. Journal of the American Society for Mass Spectrometry.
Crossref
Crossref
Joschka Bauer, Nandhini Rajagopal, Priyanka Gupta, Pankaj Gupta, Andrew E. Nixon & Sandeep Kumar. (2023) How can we discover developable antibody-based biotherapeutics?. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Brittney J. Mills, Malika P. Godamudunage, Siyuan Ren & Malabika Laha. (2023) Predictive Nature of High-Throughput Assays in ADC Formulation Screening. Journal of Pharmaceutical Sciences 112:7, pages 1821-1831.
Crossref
Crossref
Satish Rojekar, Anusha R Pallapati, Judit Gimenez-Roig, Funda Korkmaz, Farhath Sultana, Damini Sant, Clement M Haeck, Anne Macdonald, Se-Min Kim, Clifford J Rosen, Orly Barak, Marcia Meseck, John Caminis, Daria Lizneva, Tony Yuen & Mone Zaidi. (2023) Development and biophysical characterization of a humanized FSH–blocking monoclonal antibody therapeutic formulated at an ultra-high concentration. eLife 12.
Crossref
Crossref
Nicholas Skar-Gislinge, Fabrizio Camerin, Anna Stradner, Emanuela Zaccarelli & Peter Schurtenberger. (2023) Using Cluster Theory to Calculate the Experimental Structure Factors of Antibody Solutions. Molecular Pharmaceutics 20:5, pages 2738-2753.
Crossref
Crossref
Cheng Zhang, Jordan W. ByeLok H. LuiHongyu ZhangJohn Hales, Steve BrocchiniRobin A. Curtis & Paul A. Dalby. (2023) Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations. Molecular Pharmaceutics 20:5, pages 2650-2661.
Crossref
Crossref
Luis Y. Rivera-Rivera, Timothy C. Moore & Sharon C. Glotzer. (2023)
Inverse design of triblock Janus spheres for self-assembly of complex structures in the crystallization slot
via
digital alchemy
. Soft Matter 19:15, pages 2726-2736.
Crossref
Crossref
Marquerita Algorri, Nina S. Cauchon, Twinkle Christian, Chelsea O'Connell & Pujita Vaidya. (2023) Patient-Centric Product Development: A Summary of Select Regulatory CMC and Device Considerations. Journal of Pharmaceutical Sciences 112:4, pages 922-936.
Crossref
Crossref
James K. Forder, Andrew J. Ilott, Erinc Sahin & Christopher J. Roberts. (2022) Simulation of high‐concentration self‐interactions for monoclonal antibodies from well‐behaved to poorly‐behaved systems. AIChE Journal 69:4.
Crossref
Crossref
Amjad Chowdhury, Neha Manohar, Geetika Guruprasad, Amy T. Chen, Alfredo Lanzaro, Marco Blanco, Keith P. Johnston & Thomas M. Truskett. (2023) Characterizing Experimental Monoclonal Antibody Interactions and Clustering Using a Coarse-Grained Simulation Library and a Viscosity Model. The Journal of Physical Chemistry B 127:5, pages 1120-1137.
Crossref
Crossref
Itzel Condado-Morales, Viktoria Sokolova, Per-Olof Wahlund, Kristine E. Heding, Sarah Auclair, Jonathan S. Kingsbury, Paolo Arosio & Nikolai Lorenzen. (2023) AF4 and PEG Precipitation as Predictive Assays for Antibody Self-Association. Molecular Pharmaceutics 20:2, pages 1323-1330.
Crossref
Crossref
Preeti G. Desai, Patrick Garidel, Francisca O. Gbormittah, Douglas E. Kamen, Brittney J. Mills, Chakravarthy N. Narasimhan, Shubhadra Singh, Elaine S.E. Stokes & Erika R. Walsh. (2023) An Intercompany Perspective on Practical Experiences of Predicting, Optimizing and Analyzing High Concentration Biologic Therapeutic Formulations. Journal of Pharmaceutical Sciences 112:2, pages 359-369.
Crossref
Crossref
Bita Taghizadeh, Mahmoud Reza Jaafari & Nosratollah Zarghami. (2022) New insight into the importance of formulation variables on parenteral growth hormone preparations: potential effect on the injection-site pain. Frontiers in Endocrinology 13.
Crossref
Crossref
Arvind Srivastava, Courtney O'Dell, Evon Bolessa, Suman McLinden, Lori Fortin & Nandkumar Deorkar. (2022) Viscosity Reduction and Stability Enhancement of Monoclonal Antibody Formulations Using Derivatives of Amino Acids. Journal of Pharmaceutical Sciences 111:10, pages 2848-2856.
Crossref
Crossref
I. Azzouz, K. Khlifi, J. Faure, H. Dhiflaoui, A. Ben Cheikh Larbi & H. Benhayoune. (2022) Mechanical behavior and corrosion resistance of sol-gel derived 45S5 bioactive glass coating on Ti6Al4V synthesized by electrophoretic deposition. Journal of the Mechanical Behavior of Biomedical Materials 134, pages 105352.
Crossref
Crossref
Takuya ShimomuraMitsuhiro SekiguchiReisa HondaMiki YamazakiMasami Yokoyama & Susumu Uchiyama. (2022) Estimation of the Viscosity of an Antibody Solution from the Diffusion Interaction Parameter. Biological and Pharmaceutical Bulletin 45:9, pages 1300-1305.
Crossref
Crossref
Daniel Molnar, Martina Röhm, Johannes Wutz, Ingrid Rivec, Annika Michel, Gina Klotz, Jürgen Hubbuch, Katharina Schindowski & Ingo Presser. (2022) A Novel MATLAB®-Algorithm-Based Video Analysis to Quantitatively Determine Solution Creeping in Intact Pharmaceutical Glass Vials. European Journal of Pharmaceutics and Biopharmaceutics 178, pages 117-130.
Crossref
Crossref
Xiaobin Xu, Aming Zhang, Yingjie Xu, Yuan Cao, Stephen Cale, Matthew Franklin, Prasad Sarangapani, Peter M. Ihnat, Haibo Qiu, Dingjiang Liu, Erica A. Pyles, Mohammed Shameem & Ning Li. (2022) Deciphering the High Viscosity of a Therapeutic Monoclonal Antibody in High Concentration Formulations by Microdialysis-Hydrogen/Deuterium Exchange Mass Spectrometry. Journal of Pharmaceutical Sciences 111:5, pages 1335-1345.
Crossref
Crossref
Amy Y. Xu, Nicholas J. Clark, Joseph Pollastrini, Maribel Espinoza, Hyo-Jin Kim, Sekhar Kanapuram, Bruce Kerwin, Michael J. Treuheit, Susan Krueger, Arnold McAuley & Joseph E. Curtis. (2022) Effects of Monovalent Salt on Protein-Protein Interactions of Dilute and Concentrated Monoclonal Antibody Formulations. Antibodies 11:2, pages 24.
Crossref
Crossref
Xiaoxu Zhong & Arezoo M. Ardekani. (2022) A model for bubble dynamics in a protein solution. Journal of Fluid Mechanics 935.
Crossref
Crossref
Josef Hartl, Sergej Friesen, Diethelm Johannsmann, Richard Buchner, Dariush Hinderberger, Michaela Blech & Patrick Garidel. (2022) Dipolar Interactions and Protein Hydration in Highly Concentrated Antibody Formulations. Molecular Pharmaceutics 19:2, pages 494-507.
Crossref
Crossref
Aisling Roche, Lorenzo Gentiluomo, Nicole Sibanda, Dierk Roessner, Wolfgang Friess, Steven P. Trainoff & Robin Curtis. (2022) Towards an improved prediction of concentrated antibody solution viscosity using the Huggins coefficient. Journal of Colloid and Interface Science 607, pages 1813-1824.
Crossref
Crossref
Chunyu Wang, Jiaxu Hong, Zhenlin Yang, Xujiao Zhou, Yuhan Yang, Yu Kong, Binfan Chen, Huifang Wu, Bin‐Zhi Qian, Dimiter S. Dimitrov, Xingtao Zhou, Yanling Wu & Tianlei Ying. (2021) Design of a Novel Fab‐Like Antibody Fragment with Enhanced Stability and Affinity for Clinical use. Small Methods 6:2.
Crossref
Crossref
Matic Proj, Mitja Zidar, Blaž Lebar, Nika Strašek, Goran Miličić, Aleš Žula & Stanislav Gobec. (2022) Discovery of compounds with viscosity-reducing effects on biopharmaceutical formulations with monoclonal antibodies. Computational and Structural Biotechnology Journal 20, pages 5420-5429.
Crossref
Crossref
Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics
153
174
.
Adriana-Michelle Wolf Pérez, Nikolai Lorenzen, Michele Vendruscolo & Pietro Sormanni. 2022. Therapeutic Antibodies. Therapeutic Antibodies
57
113
.
Jieun Lee, Jiwon Na & Youngbin Baek. (2021) Effects of Impurities from Sugar Excipient on Filtrate Flux during Ultrafiltration and Diafiltration Process. Membranes 11:10, pages 775.
Crossref
Crossref
Shawn Shouye Wang, Yifei (Susie) Yan & Kin Ho. (2021) US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives. Antibody Therapeutics 4:4, pages 262-272.
Crossref
Crossref
Derek E. Huang & Roseanna N. Zia. (2021) Toward a flow-dependent phase-stability criterion: Osmotic pressure in sticky flowing suspensions. The Journal of Chemical Physics 155:13.
Crossref
Crossref
Lucky Ahmed, Priyanka Gupta, Kyle P. Martin, Justin M. Scheer, Andrew E. Nixon & Sandeep Kumar. (2021) Intrinsic physicochemical profile of marketed antibody-based biotherapeutics. Proceedings of the National Academy of Sciences 118:37.
Crossref
Crossref
Jonathan S. Kingsbury, Michaela M. Lantz, Amandeep Saini, Michael Z. Wang & Yatin R. Gokarn. (2021) Characterization of Opalescence in low Volume Monoclonal Antibody Solutions Enabled by Microscale Nephelometry. Journal of Pharmaceutical Sciences 110:9, pages 3176-3182.
Crossref
Crossref
Iain D. G. Campuzano & Wendy Sandoval. (2021) Denaturing and Native Mass Spectrometric Analytics for Biotherapeutic Drug Discovery Research: Historical, Current, and Future Personal Perspectives. Journal of the American Society for Mass Spectrometry 32:8, pages 1861-1885.
Crossref
Crossref
Maja Bjelošević & Pegi Ahlin Grabnar. (2021) Effects of monoclonal antibody concentration and type of bulking agent on critical quality attributes of lyophilisates. Journal of Drug Delivery Science and Technology 63, pages 102510.
Crossref
Crossref
Sébastien Brûlé, Raffaele Leroux, Patrick England & Bertrand Raynal. (2021) Protein intrinsic viscosity determination with the Viscosizer TD instrument: reaching beyond the initially expected applications. European Biophysics Journal 50:3-4, pages 587-595.
Crossref
Crossref
Donald J. AbrahamYao‐ming Huang, Brian Bowes, Tzung‐Horng Yang, James N. Thomas, S. Sam Guhan & Dean K. Pettit. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
68
.
Derek M. Mason, Simon Friedensohn, Cédric R. Weber, Christian Jordi, Bastian Wagner, Simon M. Meng, Roy A. Ehling, Lucia Bonati, Jan Dahinden, Pablo Gainza, Bruno E. Correia & Sai T. Reddy. (2021) Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning. Nature Biomedical Engineering 5:6, pages 600-612.
Crossref
Crossref
Jeremy M. Schieferstein, Paul Reichert, Chakravarthy N. Narasimhan, Xiaoyu Yang & Patrick S. Doyle. (2021) Hydrogel Microsphere Encapsulation Enhances the Flow Properties of Monoclonal Antibody Crystal Formulations. Advanced Therapeutics 4:4.
Crossref
Crossref
Pin-Kuang Lai, Amendra Fernando, Theresa K. Cloutier, Yatin Gokarn, Jifeng Zhang, Walter Schwenger, Ravi Chari, Cesar Calero-Rubio & Bernhardt L. Trout. (2021) Machine Learning Applied to Determine the Molecular Descriptors Responsible for the Viscosity Behavior of Concentrated Therapeutic Antibodies. Molecular Pharmaceutics 18:3, pages 1167-1175.
Crossref
Crossref
Danika Rodrigues, Laura M. Tanenbaum, Renuka Thirumangalathu, Sandeep Somani, Kai Zhang, Vineet Kumar, Ketan Amin & Santosh V. Thakkar. (2021) Product-Specific Impact of Viscosity Modulating Formulation Excipients During Ultra-High Concentration Biotherapeutics Drug Product Development. Journal of Pharmaceutical Sciences 110:3, pages 1077-1082.
Crossref
Crossref
Carl Mieczkowski, Alan Cheng, Thierry Fischmann, Mark Hsieh, Jeanne Baker, Makiko Uchida, Gopalan Raghunathan, Corey Strickland & Laurence Fayadat-Dilman. (2021) Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction. Antibodies 10:1, pages 8.
Crossref
Crossref
Stanislav Pantelyushin, Elisabeth Ranninger, Diego Guerrera, Gregor Hutter, Caroline Maake, Enni Markkanen, Regula Bettschart-Wolfensberger, Carla Rohrer Bley, Heinz Läubli & Johannes vom Berg. (2021) Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs. Cancers 13:4, pages 785.
Crossref
Crossref
Mario de Lucio, Miguel Bures, Arezoo M. Ardekani, Pavlos P. Vlachos & Hector Gomez. (2021) Isogeometric analysis of subcutaneous injection of monoclonal antibodies. Computer Methods in Applied Mechanics and Engineering 373, pages 113550.
Crossref
Crossref
Susan Jordan, Joshua S. Katz & Benjamin Yezer. 2021. Protein Instability at Interfaces During Drug Product Development. Protein Instability at Interfaces During Drug Product Development
249
269
.
Éva Kollár, Boglárka Balázs, Tímea Tari & István Siró. (2020) Development challenges of high concentration monoclonal antibody formulations. Drug Discovery Today: Technologies 37, pages 31-40.
Crossref
Crossref
James W. Swan, Samuel W. Winslow & William A. Tisdale. (2020) Optimal loading for injection. AIChE Journal 66:12.
Crossref
Crossref
Sunhwan Jo, Amy Xu, Joseph E. Curtis, Sandeep Somani & Alexander D. MacKerellJr.Jr.. (2020) Computational Characterization of Antibody–Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach. Molecular Pharmaceutics 17:11, pages 4323-4333.
Crossref
Crossref
Robert J. Connor, Darin M. Taverna, Karla Thrall, Michael J. LaBarre & David W. Kang. (2020) Use of computed tomography to assess subcutaneous drug dispersion with recombinant human hyaluronidase PH20 in a swine model. Journal of Pharmacological and Toxicological Methods 106, pages 106936.
Crossref
Crossref
M. Domnowski, B. Hackner, T. Neuber, J. Jaehrling & W. Frieß. (2020) Analysis of antibody self-interaction by bio-layer interferometry as tool to support lead candidate selection during preformulation and developability assessments. International Journal of Pharmaceutics 589, pages 119854.
Crossref
Crossref
Melissa Holstein, Jessica Hung, Hasin Feroz, Swarnim Ranjan, Cheng Du, Sanchayita Ghose & Zheng Jian Li. (2020) Strategies for high‐concentration drug substance manufacturing to facilitate subcutaneous administration: A review. Biotechnology and Bioengineering 117:11, pages 3591-3606.
Crossref
Crossref
Nkiruka Ibeanu, Raphael Egbu, Lesley Onyekuru, Hoda Javaheri, Peng Tee Khaw, Gareth R. Williams, Steve Brocchini & Sahar Awwad. (2020) Injectables and Depots to Prolong Drug Action of Proteins and Peptides. Pharmaceutics 12:10, pages 999.
Crossref
Crossref
Shreya S. Kulkarni, Sajal M. Patel & Robin H. Bogner. (2020) Reconstitution Time for Highly Concentrated Lyophilized Proteins: Role of Formulation and Protein. Journal of Pharmaceutical Sciences 109:10, pages 2975-2985.
Crossref
Crossref
Richard A Norman, Francesco Ambrosetti, Alexandre M J J Bonvin, Lucy J Colwell, Sebastian Kelm, Sandeep Kumar & Konrad Krawczyk. (2020) Computational approaches to therapeutic antibody design: established methods and emerging trends. Briefings in Bioinformatics 21:5, pages 1549-1567.
Crossref
Crossref
Taras Hvozd, Yurij V. Kalyuzhnyi & Vojko Vlachy. (2020) Aggregation, liquid–liquid phase separation, and percolation behaviour of a model antibody fluid constrained by hard-sphere obstacles. Soft Matter 16:36, pages 8432-8443.
Crossref
Crossref
Theresa K. Cloutier, Chaitanya Sudrik, Neil Mody, Hasige A. Sathish & Bernhardt L. Trout. (2020) Machine Learning Models of Antibody–Excipient Preferential Interactions for Use in Computational Formulation Design. Molecular Pharmaceutics 17:9, pages 3589-3599.
Crossref
Crossref
Bing Zhou, Lin Xia, Tianying Zhang, Min You, Yang Huang, Maozhou He, Ruopeng Su, Jixian Tang, Juan Zhang, Shaowei Li, Zhiqiang An, Quan Yuan, Wenxin Luo & Ningshao Xia. (2020) Structure guided maturation of a novel humanized anti-HBV antibody and its preclinical development. Antiviral Research 180, pages 104757.
Crossref
Crossref
Yulei Zhang, Lina Wu, Priyanka Gupta, Alec A. Desai, Matthew D. Smith, Lilia A. Rabia, Seth D. Ludwig & Peter M. Tessier. (2020) Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity. Molecular Pharmaceutics 17:7, pages 2555-2569.
Crossref
Crossref
James R. Apgar, Amy S. P. Tam, Rhady Sorm, Sybille Moesta, Amy C. King, Han Yang, Kerry Kelleher, Denise Murphy, Aaron M. D’Antona, Guoying Yan, Xiaotian Zhong, Linette Rodriguez, Weijun Ma, Darren E. Ferguson, Gregory J. Carven, Eric M. Bennett & Laura Lin. (2020) Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design. PLOS ONE 15:5, pages e0232713.
Crossref
Crossref
Daisuke Kuroda & Kouhei Tsumoto. (2020) Engineering Stability, Viscosity, and Immunogenicity of Antibodies by Computational Design. Journal of Pharmaceutical Sciences 109:5, pages 1631-1651.
Crossref
Crossref
Martin Domnowski, Jan Jaehrling & Wolfgang Frieß. (2020) Assessment of Antibody Self-Interaction by Bio-Layer-Interferometry as a Tool for Early Stage Formulation Development. Pharmaceutical Research 37:2.
Crossref
Crossref
Lorenzo Gentiluomo, Hristo L. Svilenov, Dillen Augustijn, Inas El Bialy, Maria Laura GrecoAlina Kulakova, Sowmya Indrakumar, Sujata Mahapatra, Marcello Martinez MoralesChristin Pohl, Aisling RocheAndreas Tosstorff, Robin Curtis, Jeremy P. Derrick, Allan Nørgaard, Tarik A. Khan, Günther H. J. Peters, Alain PluenÅsmund Rinnan, Werner W. Streicher, Christopher F. van der Walle, Shahid UddinGerhard Winter, Dierk Roessner, Pernille Harris & Wolfgang Frieß. (2020) Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization. Molecular Pharmaceutics.
Crossref
Crossref
Anna Stradner & Peter Schurtenberger. (2020) Potential and limits of a colloid approach to protein solutions. Soft Matter 16:2, pages 307-323.
Crossref
Crossref
Jakob W. Buecheler, Matthias Winzer, Christian Weber & Henning Gieseler. (2020) Alteration of Physicochemical Properties for Antibody-Drug Conjugates and Their Impact on Stability. Journal of Pharmaceutical Sciences 109:1, pages 161-168.
Crossref
Crossref
Mohamed A. Megahed, Hossam S. El-Sawy & Khalid M. El-Say. 2020. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents
69
103
.
Bernardo Perez-Ramirez. 2020. Development of Biopharmaceutical Drug-Device Products. Development of Biopharmaceutical Drug-Device Products
49
69
.
Qingyan Hu, Bowen Jiang, Dingjiang Liu, Xiaolin (Charlie) Tang, Thomas Daly & Mohammed Shameem. 2020. Development of Biopharmaceutical Drug-Device Products. Development of Biopharmaceutical Drug-Device Products
343
372
.
Jacques Dumas, Sylvain Huille & Catherine Prades. (2020) Développabilité. médecine/sciences 35:12, pages 1163-1170.
Crossref
Crossref
Jinjiang Li, Yuan Cheng, Xiaodong Chen & Songyan Zheng. (2019) Impact of electroviscous effect on viscosity in developing highly concentrated protein formulations: Lessons from non-protein charged colloids. International Journal of Pharmaceutics: X 1, pages 100002.
Crossref
Crossref
Charles G Starr & Peter M Tessier. (2019) Selecting and engineering monoclonal antibodies with drug-like specificity. Current Opinion in Biotechnology 60, pages 119-127.
Crossref
Crossref
Amy Yuanyuan Xu, Maria Monica Castellanos, Kevin Mattison, Susan Krueger & Joseph E. Curtis. (2019) Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering. Molecular Pharmaceutics 16:10, pages 4319-4338.
Crossref
Crossref
Pankaj Rohilla, Yatish S. Rane, Idera Lawal, Andrew Le Blanc, Justin Davis, James B. Thomas, Cormak Weeks, Whitney Tran, Paul Fisher, Kate E. Broderick, Jonathan A. Simmons & Jeremy O. Marston. (2019) Characterization of jets for impulsively-started needle-free jet injectors: Influence of fluid properties. Journal of Drug Delivery Science and Technology 53, pages 101167.
Crossref
Crossref
Wei Wang & Satoshi Ohtake. (2019) Science and art of protein formulation development. International Journal of Pharmaceutics 568, pages 118505.
Crossref
Crossref
Theresa Cloutier, Chaitanya Sudrik, Neil Mody, Hasige A. Sathish & Bernhardt L. Trout. (2019) Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity. Molecular Pharmaceutics 16:8, pages 3657-3664.
Crossref
Crossref
Moritz Beck-Broichsitter. (2019) Making Concentrated Antibody Formulations Accessible for Vibrating-Mesh Nebulization. Journal of Pharmaceutical Sciences 108:8, pages 2588-2592.
Crossref
Crossref
Haeri, Blaffert, Schöffmann, Blech, Hartl, Garidel & Hinderberger. (2019) Concentration Effects in the Interaction of Monoclonal Antibodies (mAbs) with their Immediate Environment Characterized by EPR Spectroscopy. Molecules 24:14, pages 2528.
Crossref
Crossref
Danlin Yang, Rachel Kroe-Barrett, Sanjaya Singh & Thomas Laue. (2019) IgG Charge: Practical and Biological Implications. Antibodies 8:1, pages 24.
Crossref
Crossref
Yu V Kalyuzhnyi & V Vlachy. (2018) Modeling the depletion effect caused by an addition of polymer to monoclonal antibody solutions. Journal of Physics: Condensed Matter 30:48, pages 485101.
Crossref
Crossref
Maryam Shah. (2018) Commentary: New perspectives on protein aggregation during Biopharmaceutical development. International Journal of Pharmaceutics 552:1-2, pages 1-6.
Crossref
Crossref
Miha Kastelic, Ken A. Dill, Yura V. Kalyuzhnyi & Vojko Vlachy. (2018) Controlling the viscosities of antibody solutions through control of their binding sites. Journal of Molecular Liquids 270, pages 234-242.
Crossref
Crossref
Jacob Blaffert, Haleh Hashemi Haeri, Michaela Blech, Dariush Hinderberger & Patrick Garidel. (2018) Spectroscopic methods for assessing the molecular origins of macroscopic solution properties of highly concentrated liquid protein solutions. Analytical Biochemistry 561-562, pages 70-88.
Crossref
Crossref
Mahlet A. Woldeyes, Lilian L. Josephson, Danielle L. Leiske, William J. Galush, Christopher J. Roberts & Eric M. Furst. (2018) Viscosities and Protein Interactions of Bispecific Antibodies and Their Monospecific Mixtures. Molecular Pharmaceutics 15:10, pages 4745-4755.
Crossref
Crossref
Mary E. Krause, Ajit S. Narang, Gregory Barker, Sibylle Herzer, Smeet Deshmukh, Wenkui Lan, Daniel Fichana, John M. Wasylyk, Bahar Demirdirek, Limin Zhang, John Fiske, Matthew McGann, Monica L. Adams & Rajesh B. Gandhi. (2018) Buffer exchange path influences the stability and viscosity upon storage of a high concentration protein. European Journal of Pharmaceutics and Biopharmaceutics 131, pages 60-69.
Crossref
Crossref
Youngbin Baek & Andrew L Zydney. (2018) Intermolecular interactions in highly concentrated formulations of recombinant therapeutic proteins. Current Opinion in Biotechnology 53, pages 59-64.
Crossref
Crossref
Dheeraj S. Tomar, Satish K. Singh, Li Li, Matthew P. Broulidakis & Sandeep Kumar. (2018) In Silico Prediction of Diffusion Interaction Parameter (kD), a Key Indicator of Antibody Solution Behaviors. Pharmaceutical Research 35:10.
Crossref
Crossref
Margarida Viola, Joana Sequeira, Raquel Seiça, Francisco Veiga, João Serra, Ana C. Santos & António J. Ribeiro. (2018) Subcutaneous delivery of monoclonal antibodies: How do we get there?. Journal of Controlled Release 286, pages 301-314.
Crossref
Crossref
Danlin Yang, John J. Correia, Walter F. Stafford III, Christopher J. Roberts, Sanjaya Singh, David Hayes, Rachel Kroe‐Barrett, Andrew Nixon & Thomas M. Laue. (2018) Weak IgG self‐ and hetero‐association characterized by fluorescence analytical ultracentrifugation. Protein Science 27:7, pages 1334-1348.
Crossref
Crossref
Kristina Kemter, Jens Altrichter, Roland Derwand, Thomas Kriehuber, Eva Reinauer & Martin Scholz. (2018) Amino Acid-Based Advanced Liquid Formulation Development for Highly Concentrated Therapeutic Antibodies Balances Physical and Chemical Stability and Low Viscosity. Biotechnology Journal 13:7, pages 1700523.
Crossref
Crossref
Maarten Batens, Jan Massant, Bianca Teodorescu & Guy Van den Mooter. (2018) Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray drying: Models and pitfalls. European Journal of Pharmaceutics and Biopharmaceutics 127, pages 407-422.
Crossref
Crossref
Miha Kastelic & Vojko Vlachy. (2018) Theory for the Liquid–Liquid Phase Separation in Aqueous Antibody Solutions. The Journal of Physical Chemistry B 122:21, pages 5400-5408.
Crossref
Crossref
Cesar Calero-Rubio, Ranendu Ghosh, Atul Saluja & Christopher J. Roberts. (2018) Predicting Protein-Protein Interactions of Concentrated Antibody Solutions Using Dilute Solution Data and Coarse-Grained Molecular Models. Journal of Pharmaceutical Sciences 107:5, pages 1269-1281.
Crossref
Crossref
Claudia Mueller, Ulrike Altenburger & Silke Mohl. (2018) Challenges for the pharmaceutical technical development of protein coformulations. Journal of Pharmacy and Pharmacology 70:5, pages 666-674.
Crossref
Crossref
Sandeep Kumar, Nikolay V Plotnikov, Jason C Rouse & Satish K Singh. (2018)
Biopharmaceutical Informatics: supporting biologic drug development
via
molecular modelling and informatics
. Journal of Pharmacy and Pharmacology 70:5, pages 595-608.
Crossref
Crossref
Mark C. Manning, Jun Liu, Tiansheng Li & Ryan E. Holcomb. 2018. Therapeutic Proteins and Peptides. Therapeutic Proteins and Peptides
1
59
.
Deirdre Murphy Piedmonte, Jian Hua Gu, Stephen R. Brych & Monica M. Goss. 2018. Challenges in Protein Product Development. Challenges in Protein Product Development
163
187
.
Olivier Marcq. 2018. Innovations for Next-Generation Antibody-Drug Conjugates. Innovations for Next-Generation Antibody-Drug Conjugates
113
161
.
Vijay Raghavan & Prasad L. Polavarapu. (2017) Specific optical rotation is a versatile tool for the identification of critical micelle concentration and micellar growth of tartaric acid–based diastereomeric amphiphiles. Chirality 29:12, pages 836-846.
Crossref
Crossref
Pietro Sormanni, Leanne Amery, Sofia Ekizoglou, Michele Vendruscolo & Bojana Popovic. (2017) Rapid and accurate in silico solubility screening of a monoclonal antibody library. Scientific Reports 7:1.
Crossref
Crossref
Maria Monica Castellanos, Nicholas J. Clark, Max C. Watson, Susan Krueger, Arnold McAuley & Joseph E. Curtis. (2016) Role of Molecular Flexibility and Colloidal Descriptions of Proteins in Crowded Environments from Small-Angle Scattering. The Journal of Physical Chemistry B 120:49, pages 12511-12518.
Crossref
Crossref
Prasad S. Sarangapani, Justin Weaver, Arun Parupudi, Tabot M.D. Besong, Gary G. Adams, Stephen E. Harding, Prakash Manikwar, Maria M. Castellanos, Steven M. Bishop & Jai A. Pathak. (2016) Both Reversible Self-Association and Structural Changes Underpin Molecular Viscoelasticity of mAb Solutions. Journal of Pharmaceutical Sciences 105:12, pages 3496-3506.
Crossref
Crossref
Lea L. Sorret, Madison A. DeWinter, Daniel K. Schwartz & Theodore W. Randolph. (2016) Challenges in Predicting Protein-Protein Interactions from Measurements of Molecular Diffusivity. Biophysical Journal 111:9, pages 1831-1842.
Crossref
Crossref
Zhiqiang Chen, Chao Huang, Naresh Chennamsetty, Xuankuo Xu & Zheng Jian Li. (2016) Insights in understanding aggregate formation and dissociation in cation exchange chromatography for a structurally unstable Fc-fusion protein. Journal of Chromatography A 1460, pages 110-122.
Crossref
Crossref